Due to the fact that the assessment of those substances has been delayed for reasons beyond the control of the applicants, the approvals of those active substances are likely to expire before a decision is taken on their renewal. It is therefore necessary to extend their approval periods by one year.
Recital 7, Regulation (EU) 2020/1511
In forcesince 16 Oct 2020